Author(s): Rasha Hasan Jasim, Hadeer Haider Abdualameer


DOI: 10.52711/0974-360X.2021.00552   

Address: Rasha Hasan Jasim, Hadeer Haider Abdualameer
Department of Chemistry, Faculty of Education for Girls, University of Kufa, Iraq.
*Corresponding Author

Published In:   Volume - 14,      Issue - 6,     Year - 2021

During the period from the beginning of December 2018 to the end of May 2019, 108 resident of Babylon were included to participate in the current study, were divided into two main groups: 81 patients with GIT diseases, their age ranged from 12-80 years; and the controls group (27 individuals) with the age 17-71 years old. Furthermore, the patient group was divided into two subgroups, the first involved 51 patients with GIT tumors and the other with non-tumoral diseases of GIT (30 individuals suffered non tumoral GIT illness were enrolled as a pathological control group). CLEC4L, Serotonin were evaluated in the sera samples of the study groups. The current study revealed statistical significant increase in the levels of serotonin while it showed significant decrease in the levels of CLEC4L in the sera testers of patients with malignant GIT tumors when compared to benign GIT tumors, pathological GIT control, and healthy control groups. The present study showed that the relationship between CLEC4E with serotonin became negative. Serotonin showed the (88%) sensitivity among the assessed criteria followed by CLEC4L (76%).

Cite this article:
Rasha Hasan Jasim, Hadeer Haider Abdualameer. CLEC4E as a New Tumor Marker for Early Diagnosis of GIT Tumors. Research Journal of Pharmacy and Technology. 2021; 14(6):3167-2. doi: 10.52711/0974-360X.2021.00552

Rasha Hasan Jasim, Hadeer Haider Abdualameer. CLEC4E as a New Tumor Marker for Early Diagnosis of GIT Tumors. Research Journal of Pharmacy and Technology. 2021; 14(6):3167-2. doi: 10.52711/0974-360X.2021.00552   Available on:

1.    Sampada S. Sawant, Vishal R. Randive, Savita R. Kulkarni. Lectins from seeds of Abrus precatorius: Evaluation of Antidiabetic and Antihyperlipidemic Potential in Diabetic Rats. Asian J. Pharm. Res. 2017; 7(2): 71-80.
2.    Reyes-Montaño Edgar Antonio, and Nohora Angélica Vega-Castro. 2018. “Plant Lectins with Insecticidal and Insectistatic Activities.” Insecticides-Agriculture and Toxicology [Prieiga per Internetą 2018-11-03]. InTech, 17–41.
3.    Silva José Dayvid Ferreira da, Suéllen Pedrosa da Silva, Pollyanna Michelle da Silva, Amanda Mota Vieira, Larissa Cardoso Correa de Araújo, Thâmarah de Albuquerque Lima, Ana Patrícia Silva de Oliveira, Lidiane Vasconcelos do Nascimento Carvalho, Maira Galdino da Rocha Pitta, and Moacyr Jesus Barreto de Melo Rêgo. 2019. “Portulaca Elatior Root Contains a Trehalose-Binding Lectin with Antibacterial and Antifungal Activities.” International Journal of Biological Macromolecules 126: 291–97.
4.    Felenda Jennifer E, Claudia Turek, and Florian C Stintzing. 2019. “Antiproliferative Potential from Aqueous Viscum Album L. Preparations and Their Main Constituents in Comparison with Ricin and Purothionin on Human Cancer Cells.” Journal of Ethnopharmacology 236: 100–107.
5.    Santos AF, da Silva MD, Napoleão TH, Paiva PM, Correia MD, Coelho LC. 2014. “Lectins: Function, Structure, Biological Properties Andpotential Applications.” Current Topics in Peptide and Protein Research 15: 41-62. Article.
6.    Lagarda-Diaz Irlanda, Ana Maria Guzman-Partida, and Luz Vazquez-Moreno. 2017. “Legume Lectins: Proteins with Diverse Applications.” International Journal of Molecular Sciences 18 (6): 1242.
7.    Liu Ailin, Carolina A Contador, Kejing Fan, and Hon-Ming Lam. 2018. “Interaction and Regulation of Carbon, Nitrogen, and Phosphorus Metabolisms in Root Nodules of Legumes.”Frontiers in Plant Science 9: 1860.
8.    Ferriz-Martinez Roberto A, Iovanna C Torres-Arteaga, Alejandro Blanco-Labra, and Teresa Garcia-Gasca. 2010. “The Role of Plant Lectins in Cancer Treatment.”Nova Sci, 71–90.
9.    Coelho Luana Cassandra Breitenbach Barroso, Priscila Marcelino dos Santos Silva, Vera Lúcia de Menezes Lima, Emmanuel Viana Pontual, Patrícia Maria Guedes Paiva, Thiago Henrique Napoleao, and Maria Tereza dos Santos Correia. 2017. “Lectins, Interconnecting Proteins with Biotechnological/Pharmacological and Therapeutic Applications.” Evidence-Based Complementary and Alternative Medicine, Hindawi: 1594074. Article.
10.    Końska G, U Wójtowicz, and A Pituch-Noworolska. 2008. “Possible Application of Lectins in Diagnostics and Therapy. Part I. Diagnostic Application.” Przeglad Lekarski 65 (4): 189–94.
11.    Mammadova-Bach Elmina, Maximilian Mauler, Attila Braun, and Daniel Duerschmied. 2017. “Immuno-Thrombotic Effects of Platelet Serotonin.” Serotonin-A Chemical Messenger Between All Types of Living Cells.
12.    Terry Natalie, and Kara Gross Margolis. 2016. “Serotonergic Mechanisms Regulating the GI Tract: Experimental Evidence and Therapeutic Relevance.” In Gastrointestinal Pharmacology, 319–42. Springer.
13.    Lv Junhua, and Feng Liu. 2017. “The Role of Serotonin beyond the Central Nervous System during Embryogenesis.”Frontiers in Cellular Neuroscience 11: 74.
14.    Rhea Elizabeth M, and William A Banks. 2019. “Role of the Blood-Brain Barrier in Central Nervous System Insulin Resistance.”Frontiers in Neuroscience 13.
15.    Periayah Mercy Halleluyah, Ahmad Sukari Halim, and Arman Zaharil Mat Saad. 2017. “Mechanism Action of Platelets and Crucial Blood Coagulation Pathways in Hemostasis.”International Journal of Hematology-Oncology and Stem Cell Research 11 (4): 319.
16.    WeinsteinScott A and Julian White. 2018. “Toxins From Venoms and Poisons.”Medical Aspects of Biological Warfare, 2nd Edd.
17.    Yabut Julian M, Justin D Crane, Alexander E Green, Damien J Keating, Waliul I Khan, and Gregory R Steinberg. 2019. “Emerging Roles for Serotonin in Regulating Metabolism: New Implications for an Ancient Molecule.”Endocrine Reviews 40 (4): 1092–1107.
18.    Somayeh Zaminpira, Sorush Niknamian. 2018. "The Impact of the Serotonin on the Cause and Treatment of Cancer." International Journal of Cancer and Oncology 5(1): 1- 7.
19.    Vinik, Aaron, Marybeth S Hughes, Eric Feliberti, Roger R Perry, Carolina Casellini, Mark Sinesi, Harlan Vingan, and Lester Johnson. 2018. “Carcinoid Tumors.” In Endotext [Internet]. MDText. com, Inc. Virginia.
20.    Afshar-Kharghan Vahid. 2017. “The Role of the Complement System in Cancer.” The Journal of Clinical Investigation 127 (3): 780–89.
21.    Oliveira Isabel, António Nunes, Ana Lima, Pedro Borralho, Cecília Rodrigues, Ricardo Boavida Ferreira, and Ana Cristina Ribeiro. 2019. “New Lectins from Mediterranean Flora. Activity against HT29 Colon Cancer Cells.”International Journal of Molecular Sciences 20 (12): 3059.
22.    Zakiryanova Gulnur K, Sarah Wheeler, and Michael R Shurin. 2018. “Oncogenes in Immune Cells as Potential Therapeutic Targets.” ImmunoTargets and Therapy 7: 21.
23.    Lewandowska Anna Maria, Marcin Rudzki, Sławomir Rudzki, Tomasz Lewandowski, and Barbara Laskowska. 2019. “Environmental Risk Factors for Cancer-Review Paper.”Annals of Agricultural and Environmental Medicine: AAEM 26 (1): 1–7.
24.    Gorakshakar Ajit C, and Kanjaksha Ghosh. 2016. “Use of Lectins in Immunohematology.”Asian Journal of Transfusion Science 10 (1): 12.
25.    Zarogoulidis Paul, Kosmas Tsakiridis, Chrisanthi Karapantzou, Sofia Lampaki, Ioannis Kioumis, Georgia Pitsiou, Antonis Papaiwannou, Wolfgang Hohenforst-Schmidt, Haidong Huang, and George Kesisis. 2015. “Use of Proteins as Biomarkers and Their Role in Carcinogenesis.”Journal of Cancer 6 (1): 9.
26.    Hashim O H, Jayapalan J J, and Lee C S. 2017. “Lectins: An Effective Tool for Screening of Potential Cancer Biomarkers.”PeerJ 5: e3784.
27.    Nisihara Renato, Thelma Skare, Vinícius Maestri, Juliana S Alegretti, Ana Paula B Campos, and Iara Messias-Reason. 2018. “Mannose-Binding Lectin (MBL) Deficiency and Tuberculosis Infection in Patients with Ankylosing Spondylitis.”Clinical Rheumatology 37 (2): 555–58.
28.    Lerner Aaron, and Torsten Matthias. 2019. “Celiac Disease Clinical, Pathophysiological, Epidemiological and Therapeutical Repertoire Is Expanding.” International Journal 7 (3): 66–68.
29.    Petty Amy J, and Yiping Yang. 2019. “Tumor-Associated Macrophages in Hematologic Malignancies: New Insights and Targeted Therapies.”Cells 8 (12): 1526.
30.    Dorszewska Jolanta, Jolanta Florczak-Wyspianska, Marta Kowalska, Marcin Stanski, Alicja Kowalewska, and Wojciech Kozubski. 2017. “Serotonin in Neurological Diseases.”Serotonin: A Chemical Messenger Between All Types of Living Cells, 219.
31.    Baudry Anne, Mathea Pietri, Jean-Marie Launay, Odile Kellermann, and Benoit Schneider. 2019. “Multifaceted Regulations of the Serotonin Transporter: Impact on Antidepressant Response.” Frontiers in Neuroscience 13: 91.
32.    Jasim Rasha Hasan, and Noor Sabah Matlab. 2017b.“Serotonin as a Marker to the Response of Patients with Advanced Stages of Cancer during Treatment with Chemotherapy and Radiotherapy.”Clin. Med. Biochem 3: 132.
33.    Jasim Rasha Hasan. 2019. “A Comparison Study among Several Tumor Markers in Serum Samples of Patients with Colon Cancers.” Indian Journal of Public Health Research & Development 10 (4): 1518–24.
34.    Hejazi Seyed Hesam, Ghasem Ahangari, Majid Pornour, Abdolkhaleagh Deezagi, Saeed Aminzadeh, Hamid Reza Ahmadkhaniha, and Mohamad Esmail Akbari. 2014. “Evaluation of Gene Expression Changes of Serotonin Receptors, 5-HT3AR and 5-HT2AR as Main Stress Factors in Breast Cancer Patients.”Asian Pacific Journal of Cancer Prevention 15 (11): 4455–58.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

56th percentile
Powered by  Scopus

SCImago Journal & Country Rank

Recent Articles


Not Available